Reported Standalone quarterly numbers for Procter & Gamble Health are:Net Sales at Rs 219.15 crore in March 2021 down 3.93% from Rs. 228.11 crore in March 2020.
Quarterly Net Profit at Rs. 15.77 crore in March 2021 down 66.06% from Rs. 46.46 crore in March 2020.
EBITDA stands at Rs. 33.97 crore in March 2021 down 50.77% from Rs. 69.00 crore in March 2020.
Procter&Gamble EPS has decreased to Rs. 9.50 in March 2021 from Rs. 27.99 in March 2020.
Procter&Gamble shares closed at 5,854.50 on June 25, 2021 (NSE) and has given -15.40% returns over the last 6 months and 39.41% over the last 12 months.
| Procter & Gamble Health | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'21 | Dec'20 | Mar'20 | | Net Sales/Income from operations | 219.15 | 240.22 | 228.11 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 219.15 | 240.22 | 228.11 | | EXPENDITURE | | Consumption of Raw Materials | 77.50 | 46.67 | 64.84 | | Purchase of Traded Goods | 3.60 | 4.26 | 7.35 | | Increase/Decrease in Stocks | -14.32 | 12.65 | 8.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 37.55 | 33.49 | 23.16 | | Depreciation | 7.67 | 7.85 | 4.24 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 84.10 | 54.40 | 66.03 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 23.06 | 80.90 | 54.50 | | Other Income | 3.24 | 5.72 | 10.26 | | P/L Before Int., Excpt. Items & Tax | 26.30 | 86.62 | 64.76 | | Interest | 0.20 | 0.19 | -- | | P/L Before Exceptional Items & Tax | 26.10 | 86.43 | 64.76 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 26.10 | 86.43 | 64.76 | | Tax | 10.33 | 18.55 | 18.30 | | P/L After Tax from Ordinary Activities | 15.77 | 67.88 | 46.46 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 15.77 | 67.88 | 46.46 | | Equity Share Capital | 16.60 | 16.60 | 16.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 9.50 | 40.90 | 27.99 | | Diluted EPS | 9.50 | 40.90 | 27.99 | | EPS After Extra Ordinary | | Basic EPS | 9.50 | 40.90 | 27.99 | | Diluted EPS | 9.50 | 40.90 | 27.99 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
